In the past ten years, the shares of Hyderabad-based, CCL Products (India) (CCLP) have returned almost 1,500 per cent returns to its stockholders. The company's 52-week high was Rs 514.95 on February 2, 2022, having a market capitalisation of more than Rs 5,480 crore as of July 15. 

The Indian markets opened on a positive note but dropped from the day’s high in the mid-morning session and thereafter, traded with mild gains.

On Thursday, the frontline indices ended with minor losses due to negative global cues. Oil and gas, pharmaceutical, and healthcare stocks were in high demand.

Following the upward trend in the Asian stocks, the major equity indices are currently trading with decent gains.

These five pharmaceutical businesses have virtually become multi-baggers and produced significant returns despite the volatility. Let’s find out what are those:  

Indian markets began the trading session on a positive note on the back of mixed global cues despite concerns over the rising recession and inflation.

The Indian bourses i.e. Sensex and Nifty fell on Tuesday amid the fear of rising interest rates and global inflation. 

The domestic equity indices witnessed losses in the opening trade. When the trading began, the metal, auto & FMCG stocks fell whereas the shares of power, oil & gas, and healthcare rose.

Q1 FY2022-23 disbursements stand at Rs 22.56 crore (highest quarterly disbursement to date).

The Tata Group and Honeywell established Honeywell Automation India Limited (HAIL) as a joint venture. Previously known as Tata Honeywell Limited, the corporation was owned by each of them to the tune of 39.54 per cent.